Fluad Injection, Suspension
Product Images NDC 70461-026

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fluad (NDC 70461-026). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Seqirus, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Flu2e 0013 01

FLUAD Influenza Vaccine, Adjuvanted 15 mcg/.5 mL pre-filled syringes, presented in a carton for the 2024-2025 formula. It is indicated for adults 65 years of age and older. The packaging states single-dose usage for intramuscular administration and lists Seqirus, Inc. as the labeler. The carton contains ten 0.5 mL syringes.*

FDA Label Image

Flu2e 0013 02

Label for FLUAD Influenza Vaccine, Adjuvanted 2024 - 2025 Formula. The label indicates a 0.5 mL dose for intramuscular use, intended for adults 65 years and older. Manufactured by Seqirus Inc., with US License No. 2049. Includes NDC 70461-024-04 and placeholders for lot and expiration dates.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.